CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and internationally. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Software visualization tools. It also provides software CurveBeam AI Autometrics for automatically segment foot and ankle datasets; Axiometrics, provides a semi-automatic measurement of the axes of rotation of the hip, femur, knee, and ankle; and TALAS, a measurement tool that semi-automatically calculate hindfoot alignment based on reproducible three-dimensional anatomical landmarks. In addition, the company offers custom web-based cloud platform; and OSSView. The company was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.
Frequently asked questions
What sector does CRVAF (CRVAF) operate in?
CRVAF belongs to the Other sector and operates in the Medical Devices industry.
What is CRVAF (CRVAF) current stock price?
As of the latest data, CRVAF stock price is $0.05, with a previous close of $0.05.
What is CRVAF (CRVAF) current market capitalization?
CRVAF market cap is approximately 20.92 million.
What is CRVAF (CRVAF) Earnings Per Share (EPS)?
The trailing EPS is -$0.03.
Does CRVAF (CRVAF) pay dividends?
No. CRVAF does not pay a dividend.
What is CRVAF (CRVAF) beta (volatility) score?
CRVAF has a beta of 1.715, suggesting it is more volatile than the market.
